By clicking "Accept" on the Cookie banner, you give us your consent to store and access Cookies and Other Tracking Technologies as described in this Cookie Policy.
Accept
Pharmosa Biopharm Inc. (PBI) is applying our proprietary liposome technology to create the innovative nanoparticle formulation with existing drug. We are focusing on development of drug-device combination product through 505(b)2 or hybrid regulatory pathway.